Broader Financial Turmoil Threatens Biotech's Innovation and Cash

New York Times - United States
Robert I. Blum, the chief executive of Cytokinetics, says pressure to abandon earlier-stage research hurts drug innovation. But for them, runway refers to ...
See Full Post